Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Alimentary tract cancer patients treated at National Cheng Kung University Hospital during 2013/01/01 to 2020/12/31 were reviewed.
We would like to explore the treatment strategy and clinical outcome of alimentary tract cancer in National Cheng Kung University Hospital. The result could help physician to further realize the real world practice of cancer treatment in Taiwan and might also help clinician to optimize the diagnosis and treatment strategy in alimentary tract cancer patients. Alimentary tract cancer patients treated at National Cheng Kung University Hospital during 2013/01/01 to 2020/12/31.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Resectable | Patients with resectable pancreatic cancer | ||
| Borderline resectable | Patients with borderline resectable pancreatic cancer | ||
| Locally advanced | Patients with locally advanced unresectable pancreatic cancer | ||
| Metastatic | Patients with metastatic pancreatic cancer |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Overall survival (OS) | Overall survival of patient received study treatment | 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| Progression-free survival (PFS) | Progression-free survival of patient received study treatment | 10 years |
Not provided
Inclusion Criteria:
All patients with pancreatic cancer treated at National Cheng Kung University Hospital during 2013/01/01 to 2020/12/31
Exclusion Criteria:
No treatment or refuse treatment
Not provided
Not provided
Not provided
All patients with pancreatic cancer treated at National Cheng Kung University Hospital during 2013/01/01 to 2020/12/31 were retrospectively reviewed.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Cheng-Kung University Hospital | Tainan | Taiwan | ||||
| National Institute of Cancer Research |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37300888 | Derived | Su YY, Chao YJ, Wang CJ, Liao TK, Su PJ, Huang CJ, Chiang NJ, Yu YT, Tsai HM, Chen LT, Shan YS. The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study. Int J Surg. 2023 Sep 1;109(9):2614-2623. doi: 10.1097/JS9.0000000000000495. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Formalin-fixed, paraffin-embedded (FFPE) tissue sample before or after treatment will be collected for next generation sequencing
| Tainan |
| Taiwan |